Glyxambi is an SGLT2 inhibitor used in combination with diet and exercise to improve glycemic control and lower blood sugar in adults with type 2 diabetes. SGLT2 inhibitors lower a person’s blood sugar by causing the kidneys to remove it through the urine. Invokana lawsuits allege that the manufacturers and marketers of SGLT2 inhibitors failed to warn patients and physicians of the increased risks of the kidney failure, other cardiovascular issues, and ketoacidosis.

The failure to warn patients of the possible risks the type 2 diabetes drug is capable of creating, is leading to a demand for lawsuits. Other SGLT2 inhibitor lawsuits state that if manufacturers and marketers had properly warned of the risks, patients would have been prescribed and taken a substitute medication for their diabetes, and would have had their health monitored on a more routine basis for potential signs of heart issues, renal impairment, and high level of ketones.

Why is Glyxambi Dangerous?

Patients taking Glyxambi have reported cases of ketoacidosis, another serious and life-threatening condition that requires immediate medical treatment. It is caused by a lack of glucose, which causes the body to burn fat for energy. This causes a buildup of ketones in the blood, which makes it acidic. If not treated properly it can cause more complications and continuation of the medication can lead to high risk penalties.

Later signs include but are not limited to:

  • fatigue
  • dry and flushed skin
  • nausea
  • vomiting
  • abdominal pain
  • fruity breath
  • confusion
  • trouble breathing

If you have taken Glyxambi and are concerned about its safety, talk to your doctor about the risks to file a potential lawsuit case against this dangerous drug.

FDA Issues Recommendations About Dangers of Glyxambi

The U.S. Food and Drug Administration (FDA) warned patients of the risk Glyxambi has the potential of causing. The risk of acute kidney injury is very prominent and health professionals are advised to consider factors that may predispose patients to acute kidney injury before prescribing the medication. It is recommended however, to discontinue the drug and treat the kidney impairment if found after being prescribed.

In August 2015, the Food and Drug Administration (FDA) issued a warning that 11 relatively new diabetes drugs may cause severe and disabling joint pain, including Glyxambi.

Can I File A Glyxambi Lawsuit?

Our lawyers can help if you or someone you care about contracted a severe — or possibly fatal — infection as a result of being exposed to severe side effects this drug causes.

Our top Glyxambi case lawyers are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Both patients and their families are seeking compensation for injuries. You may be entitled to a settlement if you were harmed by Glyxambi.

Our No-Fee Promise On Glyxambi Cases

You can afford to have our great team of Glyxambi lawyers on your side. If you choose us, it literally costs you nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a Glyxambi settlement
  • Phone calls are always free

How Do I Start A Glyxambi Claim?

Our dangerous drug case lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-3417 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have a claim, we will start immediately.

WARNING: There are strict time deadlines for filing Glyxambi claims.